This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Stone, MD Mount Sinai Health System tim.hodson Wed, 04/02/2025 - 15:26 March 31, 2025 Using intravascular imaging (IVI) to guide stent implantation during complex stenting procedures is safer and more effective for patients with severely calcified coronary artery disease than conventional angiography, the more commonly used technique.
tim.hodson Fri, 03/14/2025 - 16:12 SCAI Scientific Sessions 2025 will take place May 1 to 3, attheWalter E. Washington Convention Center in Washington, DC.
tim.hodson Fri, 03/28/2025 - 15:23 Mar. For CCTA to be truly effective, the CT system must be designed to address the most difficult cardiac exams, including irregularities in heart rhythms, patients with limited cooperation, and those with calcification, stents or bypasses.
Stroke, Volume 56, Issue Suppl_1 , Page AWMP94-AWMP94, February 1, 2025. Introduction:Medical therapy and endovascular therapy for intracranial atherosclerotic disease (ICAD) have evolved over the past two decades with improved medical therapy benchmarks, and improved techniques and patient selection for stenting.
Stroke, Volume 56, Issue Suppl_1 , Page ATP226-ATP226, February 1, 2025. Drug-eluting stents have shown better performance than bare metal stents. Patients will be randomized (1:1) to drug-eluting stenting plus medical therapy or medical therapy alone. Results:A total of 472 patients will be enrolled.
Stroke, Volume 56, Issue Suppl_1 , Page ADP36-ADP36, February 1, 2025. All patients had headache, and funduscopic examination demonstrated papilledema for all patients. All patients had headache, and funduscopic examination demonstrated papilledema for all patients. Additional randomized and controlled clinical research is deserved.
Stroke, Volume 56, Issue Suppl_1 , Page AWP10-AWP10, February 1, 2025. Background:Increased immediate and delayed re-occlusion rates, up to 33%, are reported in patients undergoing acute stenting for tandem lesions, with symptomatic hemorrhage rates around 10-15%. Larger studies are needed to validate these findings.
Stroke, Volume 56, Issue Suppl_1 , Page ATMP82-ATMP82, February 1, 2025. Introduction:Aspiration and stent retriever thrombectomy are the primary approaches for endovascular management of posterior circulation stroke. However, the optimal first-line choice of surgical technique remains unclear. to -0.40; p < 0.005).
Stroke, Volume 56, Issue Suppl_1 , Page ATP248-ATP248, February 1, 2025. Longer pre-stent balloon length was significantly associated with perforator SBIs (13.52.5 Conclusion:Stenosis diameter, length, and MCA tortuosity are significant factors for SBIs following MCA stenting. Efforts to reduce SBIs are needed.
Circulation, Volume 151, Issue 12 , Page 835-846, March 25, 2025. BACKGROUND:In patients with post-thrombotic syndrome, stent recanalization of iliofemoral veins or the inferior vena cava can restore venous patency and improve functional outcomes.
Stroke, Volume 56, Issue Suppl_1 , Page A39-A39, February 1, 2025. Balloon expandable stent (BES) and self-expanding stent (SES) were used in 54 and 224 patients, respectively.
Stroke, Volume 56, Issue Suppl_1 , Page ATP178-ATP178, February 1, 2025. Background:Hyperperfusion phenomenon (HPP) constitutes a significant risk factor for adverse outcomes following carotid artery stenting (CAS). Currently, the sole method for evaluating the risk of HPP post-CAS is the invasive acetazolamide (ACZ) challenge test.
Publication date: Available online 29 January 2025 Source: The American Journal of Cardiology Author(s): Sang-Suk Choi, Jin Jung, Kyunyeon Kim, Sung-Ho Her, Kyusup Lee, Doo-Soo Jeon, Byung-Hee Hwang, Chul Soo Park, Sungmin Lim, Suk Min Seo, Jisu Mok, Seung Hwan Han, Sung Uk Kwon, Joo-Yong Hahn, Seung-Whan Lee, Woong Gil Choi
Stroke, Volume 56, Issue Suppl_1 , Page AWP258-AWP258, February 1, 2025. Introduction:Surpass Evolve (SE) is an updated flow diverter stent. While shown to be effective and safe for treating intracranial aneurysms (IA), blood flow analysis is still limited.
Stroke, Volume 56, Issue Suppl_1 , Page AWP242-AWP242, February 1, 2025. To our knowledge, no studies have directly compared the right and left TRA for carotid artery stenting (CAS). Typically, the right radial artery is used in neurointerventions.
Stroke, Volume 56, Issue Suppl_1 , Page ATP229-ATP229, February 1, 2025. Background:Carotid artery stenting (CAS) and carotid endarterectomy (CEA) are two types of carotid revascularization procedures performed on symptomatic patients.
Stroke, Volume 56, Issue Suppl_1 , Page ATMP76-ATMP76, February 1, 2025. The time interval between the most recent qualifying ischemic event and CAS/CEA procedure was divided in four strata: 1-7 days, 8-14 days, 15-30 days and >30 days.
Stroke, Volume 56, Issue Suppl_1 , Page A71-A71, February 1, 2025. Background:The ideal timing of carotid artery stenting (CAS) in symptomatic internal carotid artery (ICA) stenosis is partly determined by the risk of stroke and/or death associated with timing of the procedure.
Stroke, Volume 56, Issue Suppl_1 , Page A41-A41, February 1, 2025. Introduction:Current guidelines do not support the use of stenting for severe symptomatic intracranial atherosclerotic disease (ICAD) over maximal medical therapy (MMT) as first line treatment. Periprocedural stroke was defined as <7d from stent placement.
Stroke, Volume 56, Issue 4 , Page e114-e118, April 1, 2025. The longstanding benefits of percutaneous angioplasty and stenting in coronary artery disease, where atherosclerosis is the overarching cause in nearly all cases, provided a compelling rationale for exploring similar interventions in intracranial atherosclerotic stenosis.
Stroke, Volume 56, Issue Suppl_1 , Page AWP43-AWP43, February 1, 2025. Compared with the NR group, the R group had significantly larger aneurysm size, neck size, and aneurysm volume at initial coiling and significantly lower rates of stent-assisted coiling, use of an intermediate catheter, and complete occlusion at second coiling.
Stroke, Volume 56, Issue Suppl_1 , Page ATP253-ATP253, February 1, 2025. Within the sign-positive population, the use of contact aspiration was associated with a significantly higher rate of recanalization compared to using a stent retriever (OR: 0.18; 95%CI: 0.07 0.49; P < 0.001).
Stroke, Volume 56, Issue Suppl_1 , Page ATP247-ATP247, February 1, 2025. Of the 32 patients, 9(28.1%) had dissection with diagnostic angiograms, 6(18.8%) endovascular thrombectomy, 15(46.9%) aneurysm treatment, and 2(6.3%) angioplasty with or without stenting. Only 4(12.5%) were treated with hyperacute stenting.
Circulation: Cardiovascular Interventions, Volume 18, Issue 1 , Page e014665, January 1, 2025. BACKGROUND:Bioresorbable scaffolds (BRS) were developed to overcome limitations related to late stent failures of drug-eluting stents, but lumen reductions over time after implantation of BRS have been reported.
Stroke, Volume 56, Issue Suppl_1 , Page ATMP58-ATMP58, February 1, 2025. ml/h, P = 0.04), a higher likelihood of parent artery stenosis (65% vs. 20.8%, P < 0.001), and increased need for angioplasty or stenting (50% vs. 17%, P < 0.001). ml/h vs. 7.5 The mismatch group also had a higher DWIR% (37.7% vs. 21.2%, P = 0.02).Conclusions:DWI-ADC
Stroke, Volume 56, Issue Suppl_1 , Page ATP257-ATP257, February 1, 2025. Data extracted included year of publication, estimated and actual sample sizes, observed outcomes, and statistical methods used.
Stroke, Volume 56, Issue Suppl_1 , Page AWP252-AWP252, February 1, 2025. Introduction:Underlying Intracranial atherosclerotic disease (ICAD) may influence mechanical thrombectomy recanalization, leading to an increased number of passes before rescue techniques are adopted.
Stroke, Volume 56, Issue Suppl_1 , Page AWMP93-AWMP93, February 1, 2025. They were treated via a femoral approach using conventional CTO techniques with balloon expandable and/or self-expanding stents. Neurological evaluation of NIHSS, mRankin and carotid U/S were performed at discharge, 30days, and all subsequent follow-up.
IVL helps restore blood flow by cracking calcium lesions using sonic pressure waves and is used in both CAD and PAD, often in combination with stenting. IVL is a minimally invasive, catheter-based treatment for calcified arterial lesions, which can reduce blood flow and cause pain or heart attack. in 2024 and approximately $0.17
Stroke, Volume 56, Issue Suppl_1 , Page AWP253-AWP253, February 1, 2025. EVT consists of mechanical thrombectomy, thromboaspiration, balloon dilation, stenting, intra-arterial thrombolysis, or various combinations of these methods. mg/kg of body weight, 10% administered as a bolus, followed by a 1-hour infusion of the remaining dose).
Stroke, Volume 56, Issue Suppl_1 , Page ATMP84-ATMP84, February 1, 2025. EVT technique was categorized as Stent-Retriever (SR), Contact Aspiration (CA), or a Combined Technique (CT). Prior studies have demonstrated that switching techniques between passes may improve rates of reperfusion. Exclusion criteria included incomplete data.
Stroke, Volume 56, Issue Suppl_1 , Page AWP286-AWP286, February 1, 2025. Background:Hemodynamic evaluation is crucial in assessing stroke risk in patients with symptomatic intracranial atherosclerotic stenosis (sICAS). before PTAS. before PTAS.
Stroke, Volume 56, Issue Suppl_1 , Page AWP16-AWP16, February 1, 2025. We excluded patients who had a clear contraindication to Eptifibatide, received a stent, or if the luminal stenosis was related to reactive vasospasm and any cases with TICI 0, 1, or TICI 3 scores.Results:Our sample size was 60 (51.7% female, mean age 63.9).
Stroke, Volume 56, Issue Suppl_1 , Page ATP128-ATP128, February 1, 2025. Background:Postoperative complication rates of carotid endarterectomy (CEA) and carotid artery stenting (CAS) for carotid artery stenosis are recommended to be maintained below a certain threshold.
Stroke, Volume 56, Issue Suppl_1 , Page ATMP10-ATMP10, February 1, 2025. Introduction:An optimal strategy for the treatment of intracranial atherosclerotic disease (ICAD) has remained unclear, despite medical therapy (antiplatelet therapy and LDL control management) or endovascular therapy (angioplasty or stenting).
The total occlusion was recanalized and stented from 100 to 0%. Code STEMI was calledMid LAD had serial 70 and 60 percent lesions and was occluded in the distal segmentAn excellent result was achieved. ii ) Since it is now 7 years since initial publication of the OMI Manifesto ( See the April 18, 2018 post in Dr.
Stroke, Volume 56, Issue Suppl_1 , Page ADP37-ADP37, February 1, 2025. Object:The introduction of antiplatelet agents is essential in stent-assisted coil embolization (SACE) for the treatment of intracranial aneurysms, and preoperative drug efficacy assessment is important in reducing the risk of ischemic complications.
Stroke, Volume 56, Issue Suppl_1 , Page A80-A80, February 1, 2025. In-stent stenosis occurred in 2.2% (17) and was associated with fusiform morphology at 1 year FU (OR, 4.82, 95% CI, 1.28 -14.35; p=0.018).Conclusion:Treatment Fusiform morphology was associated with in-stent stenosis. 2.56; p=0.076).
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content